摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-甲氧基-N-甲基己酰胺 | 64214-56-8

中文名称
N-甲氧基-N-甲基己酰胺
中文别名
——
英文名称
N-methoxy-N-methylhexanamide
英文别名
——
N-甲氧基-N-甲基己酰胺化学式
CAS
64214-56-8
化学式
C8H17NO2
mdl
——
分子量
159.228
InChiKey
SQJBFKIBKZWTHE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.7
  • 重原子数:
    11
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    29.5
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2924199090
  • 包装等级:
    III
  • 危险类别:
    3
  • 危险性防范说明:
    P501,P240,P210,P233,P243,P241,P242,P280,P370+P378,P303+P361+P353,P403+P235
  • 危险品运输编号:
    1993
  • 危险性描述:
    H225

SDS

SDS:7a904464216af0c9a43d5fa45c9c3926
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: N-Methoxy-N-methylhexanamide
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: N-Methoxy-N-methylhexanamide
CAS number: 64214-56-8

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H17NO2
Molecular weight: 159.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    N-甲氧基-N-甲基己酰胺苯甲酸乙酯二异丁基氢化铝 作用下, 以 四氢呋喃 为溶剂, 反应 0.5h, 以99%的产率得到正己醛
    参考文献:
    名称:
    DIBALH:从已知的基本反应到不寻常的反应;在酯存在下化学选择性部分还原叔酰胺。
    摘要:
    本研究提出了一种快速可靠的方法,可在使用商业 DIBALH 试剂的易还原酯基团存在的情况下,将叔酰胺化学选择性部分还原为醛。此外,所开发的方法还扩展到带有酯部分的多功能分子,这些分子成功地化学选择性地还原为相应的醛。
    DOI:
    10.1039/d1ra06279d
  • 作为产物:
    描述:
    2-(benzenesulfonyl)-N-methoxy-N-methylhexanamidedisodium hydrogenphosphatesodium amalgam 作用下, 以 甲醇 为溶剂, 反应 1.5h, 以69%的产率得到N-甲氧基-N-甲基己酰胺
    参考文献:
    名称:
    N-甲氧基-N-甲基-2-苯基磺酰乙酰胺作为双碳同化剂的合成及应用
    摘要:
    在众所周知的前提下,N-甲氧基-N-甲基酰胺是优秀的酰阳离子和醛的等效物,新试剂N-甲氧基-N-甲基-2-苯基磺酰乙酰胺(3)被合成,它在合成上相当于ΘCH2CHO和ΘCH2COR。3中活性亚甲基位点的烷基化过程简单,同时安全去除苯基磺酰基,使得3成为烷基卤化物的两碳同系物合成的多功能试剂。当该方法应用于糖卤化物6j和6k时,成功合成了2,3-二脱氧糖。
    DOI:
    10.1055/s-2000-6337
点击查看最新优质反应信息

文献信息

  • [EN] CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS DE LA CÉRAMIDE GALACTOSYLTRANSFÉRASE POUR LE TRAITEMENT DE MALADIES
    申请人:BIOMARIN PHARM INC
    公开号:WO2017214505A1
    公开(公告)日:2017-12-14
    Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.
    本文描述了化合物、制备这种化合物的方法、含有这种化合物的药物组合物和药物、以及使用这种化合物治疗或预防与酶神经鞘糖脂转移酶(CGT)相关的疾病或紊乱的方法,例如溶酶体贮积症。溶酶体贮积症的例子包括 Krabbe 病和白质变性白血病。
  • Strategic Application and Transformation of <i>ortho</i>-Disubstituted Phenyl and Cyclopropyl Ketones To Expand the Scope of Hydrogen Borrowing Catalysis
    作者:James R. Frost、Choon Boon Cheong、Wasim M. Akhtar、Dimitri F. J. Caputo、Neil G. Stevenson、Timothy J. Donohoe
    DOI:10.1021/jacs.5b11196
    日期:2015.12.23
    The application of an iridium-catalyzed hydrogen borrowing process to enable the formation of α-branched ketones with higher alcohols is described. In order to facilitate this reaction, ortho-disubstituted phenyl and cyclopropyl ketones were recognized as crucial structural motifs for C-C bond formation. Having optimized the key catalysis step, the ortho-disubstituted phenyl products could be further
    描述了铱催化的借氢过程在能够与高级醇形成 α-支化酮中的应用。为了促进该反应,邻位双取代的苯基和环丙基酮被认为是 CC 键形成的关键结构基序。在优化了关键催化步骤后,邻位二取代苯基产物可以通过反弗里德尔-克来福特酰化反应进一步操作,以产生合成有用的羧酸衍生物。相比之下,环丙基酮与几种亲核试剂进行同共轭加成,以提供进一步功能化的支化酮产物。
  • IONIZABLE CATIONIC LIPID FOR RNA DELIVERY
    申请人:Arcturus Therapeutics, Inc.
    公开号:US20180169268A1
    公开(公告)日:2018-06-21
    What is described is a compound of formula I consisting of a compound in which R 1 is a branched chain alkyl consisting of 10 to 31 carbons; R 2 is a linear alkyl, alkenyl, or alkynyl consisting of 2 to 20 carbons; L 1 and L 2 are the same or different, each a linear alkylene of 1 to 20 carbons or a linear alkenylene of 2 to 20 carbons; X 1 is S or O; R 3 is a linear or branched alkylene consisting of 1 to 6 carbons; and R 4 and R 5 are the same or different, each a hydrogen or a linear or branched alkyl consisting of 1 to 6 carbons; or a pharmaceutically acceptable salt thereof.
    描述的是一种化合物,其化学式为I,包括以下成分: R1为由10至31个碳组成的支链烷基化合物; R2为由2至20个碳组成的直链烷基、烯基或炔基; L1和L2相同或不同,每个为由1至20个碳组成的直链烷基或由2至20个碳组成的直链烯基; X1为S或O; R3为由1至6个碳组成的直链或支链烷基; R4和R5相同或不同,每个为氢或由1至6个碳组成的直链或支链烷基;或其药用可接受盐。
  • Discovery and Characterization of Pure RhlR Antagonists against <i>Pseudomonas aeruginosa</i> Infections
    作者:SangJin Nam、So-Young Ham、Hongmok Kwon、Han-Shin Kim、Suhyun Moon、Jeong-Hoon Lee、Taehyeong Lim、Sang-Hyun Son、Hee-Deung Park、Youngjoo Byun
    DOI:10.1021/acs.jmedchem.0c00630
    日期:2020.8.13
    Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic human pathogen that forms biofilms and produces virulence factors via quorum sensing (QS). Blocking the QS system in P. aeruginosa is an excellent strategy to reduce biofilm formation and the production of virulence factors. RhlR plays an essential role in the QS system of P. aeruginosa. We synthesized 55 analogues based on the chemical structure
    铜绿假单胞菌(P.aeruginosa)是一种机会性人类病原体,可形成生物膜并通过群体感应(QS)产生毒力因子。阻断铜绿假单胞菌的QS系统是减少生物膜形成和产生毒力因子的极好策略。RhlR在铜绿假单胞菌的QS系统中发挥重要作用。我们基于4-gingerol的化学结构合成了55个类似物,并使用基于细胞的报告基因菌株测定法评估了它们的RhlR抑制活性。全面的结构-活性关系研究确定了炔基酮30作为最有效的RhlR拮抗剂。该化合物对LasR和PqsR表现出选择性的RhlR拮抗作用,对生物膜的形成有很强的抑制作用,并减少了铜绿假单胞菌中毒力因子的产生。此外,用30只体内处理的黄粉虫幼虫的存活率大大提高。因此,化合物30,一种纯的RhlR拮抗剂,可以用于开发铜绿假单胞菌感染的QS调节分子。
  • A new class of fluorescent dyes based on 1,3-benzodioxole and [1,3]-dioxolo[4.5-f]benzodioxole
    作者:Pablo Wessig、Robert Wawrzinek、Kristian Möllnitz、Elvira Feldbusch、Uwe Schilde
    DOI:10.1016/j.tetlet.2011.09.058
    日期:2011.11
    We report on synthesis and photophysical properties of a new class of fluorescent dyes. They are characterized by large Stokes-shifts, long fluorescence lifetimes in organic solvents and a pronounced dependency of the fluorescence lifetime on the solvent polarity. Also worthy of note is the high bleaching stability. To provide access to biochemical and medical applications a series of derivatives were
    我们报告了新型荧光染料的合成和光物理性质。它们的特征在于大的斯托克斯位移,在有机溶剂中的长荧光寿命以及荧光寿命对溶剂极性的显着依赖性。还值得注意的是高的漂白稳定性。为了提供进入生物化学和医学应用的途径,制备了一系列衍生物,其对不同的生物学相关官能团(羧酸,胺,马来酰亚胺,N-羟基琥珀酰亚胺酯)表现出特定的反应性。此外,制备了两个炔烃,可用于“点击”化学。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物